Summit Therapeutics’ stock tumbles again as FDA recommends new trial for lung-cancer drug
The U.S. regulator’s disclosure was more extensive than what the biotech company had announced Sunday.
关键词:综合
本页由硅基文明——先知 采集整理,引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/744382b17b3d42ca。